Literature DB >> 2361409

Influenza in patients with human immunodeficiency virus infection.

S Safrin1, J D Rush, J Mills.   

Abstract

Although patients infected with human immunodeficiency virus (HIV) might be expected to have more severe illness due to influenza virus infection than normal persons, the course of influenza in such patients has not been well delineated. We describe six consecutive HIV-infected patients at San Francisco General Hospital in whom influenza virus was isolated from induced sputum or bronchoalveolar lavage specimens between December 1988 and March 1989. Although neither clinical presentation of influenza nor rate of secondary complications appeared to be altered from that in healthy individuals, our power of comparison was limited by small sample size. However, a high prevalence of hypoxemia and a trend toward prolonged duration of illness were identified. Larger, controlled studies are needed to define the course of influenza virus infection in HIV-infected patients as compared with nonimmunosuppressed patients.

Entities:  

Mesh:

Year:  1990        PMID: 2361409     DOI: 10.1378/chest.98.1.33

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  32 in total

1.  Differences in the epidemiological characteristics and clinical outcomes of pandemic (H1N1) 2009 influenza, compared with seasonal influenza.

Authors:  Kevin T Shiley; Gregory Nadolski; Timothy Mickus; Neil O Fishman; Ebbing Lautenbach
Journal:  Infect Control Hosp Epidemiol       Date:  2010-07       Impact factor: 3.254

2.  Increased Rates of Respiratory and Diarrheal Illnesses in HIV-Negative Persons Living With HIV-Infected Individuals in a Densely Populated Urban Slum in Kenya.

Authors:  Joshua M Wong; Leonard Cosmas; Dhillon Nyachieo; John M Williamson; Beatrice Olack; George Okoth; Henry Njuguna; Daniel R Feikin; Heather Burke; Joel M Montgomery; Robert F Breiman
Journal:  J Infect Dis       Date:  2015-02-25       Impact factor: 5.226

3.  Higher antigen content improves the immune response to 2009 H1N1 influenza vaccine in HIV-infected adults: a randomized clinical trial.

Authors:  Hana M El Sahly; Charles Davis; Karen Kotloff; Jeffery Meier; Patricia L Winokur; Anna Wald; Christine Johnston; Sarah L George; Rebecca C Brady; Corinne Lehmann; Abbie Stokes-Riner; Wendy A Keitel
Journal:  J Infect Dis       Date:  2012-01-24       Impact factor: 5.226

4.  Community-based respiratory viral infections in HIV positive patients with lower respiratory tract disease: a prospective bronchoscopic study.

Authors:  R F Miller; C Loveday; J Holton; Y Sharvell; G Patel; N S Brink
Journal:  Genitourin Med       Date:  1996-02

Review 5.  Influenza susceptibility, severity, and shedding in HIV-infected adults: a review of the literature.

Authors:  Anandi N Sheth; Keri N Althoff; John T Brooks
Journal:  Clin Infect Dis       Date:  2011-01-15       Impact factor: 9.079

Review 6.  Influenza.

Authors:  John H Beigel
Journal:  Crit Care Med       Date:  2008-09       Impact factor: 7.598

Review 7.  Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses.

Authors:  Ken M Kunisaki; Edward N Janoff
Journal:  Lancet Infect Dis       Date:  2009-08       Impact factor: 25.071

Review 8.  Vaccination in HIV-infected adults.

Authors:  Nancy F Crum-Cianflone; Mark R Wallace
Journal:  AIDS Patient Care STDS       Date:  2014-07-16       Impact factor: 5.078

9.  Rapid selection of a transmissible multidrug-resistant influenza A/H3N2 virus in an immunocompromised host.

Authors:  Matthew J Memoli; Rachel J Hrabal; Arash Hassantoufighi; Brett W Jagger; Zong-Mei Sheng; Maryna C Eichelberger; Jeffery K Taubenberger
Journal:  J Infect Dis       Date:  2010-05-01       Impact factor: 5.226

10.  Vitamin D levels and influenza vaccine immunogenicity among HIV-infected and HIV-uninfected adults.

Authors:  Nancy F Crum-Cianflone; Seunghyun Won; Rachel Lee; Tahaniyat Lalani; Anuradha Ganesan; Timothy Burgess; Brian K Agan
Journal:  Vaccine       Date:  2016-08-28       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.